Ivonescimab Combined With Chemotherapy for the Treatment of Leptomeningeal Metastases Failed to EGFR-TKIs

NCT06766591 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

36

Enrollment

OTHER

Sponsor class

Conditions

NSCLC
Chemotherapy
Leptomeningeal Metastases
EGFR-TKI
AK112

Interventions

DRUG: Ivonescimab combined with chemotherapy

Sponsor

Jiangsu Province Nanjing Brain Hospital

Collaborators

[object Object]
[object Object]